Related Experiment Video

Updated: Jul 12, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.6K

Contraception and Cardiovascular Effects: What Should the Cardiologist Know?

Anhthu Trinh1, Ankit Vyas2, Anna Roselle3

  • 1West Virginia University School of Medicine, Morgantown, WV, USA.

Current Cardiology Reports
|October 20, 2023
PubMed

Insights

Cardiovascular disease (CVD) is a leading cause of death in women. This review guides cardiologists on contraceptive safety and cardiovascular risk for women of childbearing age.

Area of Science:

  • Cardiology
  • Women's Health
  • Reproductive Health

Background:

  • Cardiovascular disease (CVD) is the primary cause of mortality in women.
  • A significant percentage of American women (44%) have some form of CVD.
  • Hormonal contraception is widely used by women, necessitating a clear understanding of its cardiovascular implications.

Purpose of the Study:

  • To review contraceptive options and their impact on the cardiovascular system (CVS).
  • To provide guidance for cardiologists on assessing contraceptive safety in women with CVD.
  • To aid in cardiovascular risk stratification for women of childbearing age using contraception.

Main Methods:

  • Comprehensive literature review of current contraceptive methods.
  • Analysis of cardiovascular effects associated with various contraceptive options.
  • Synthesis of evidence to inform clinical decision-making for cardiologists.

Main Results:

  • Contraceptive choices have varying effects on the cardiovascular system.
  • Understanding these effects is crucial for managing cardiovascular risk in women.
  • Cardiologists require up-to-date information on contraception for patient care.

Conclusions:

  • Informed decisions regarding contraceptive use are essential for women's cardiovascular health.
  • This review serves as a resource for cardiologists managing contraception in women with CVD.
  • Effective risk stratification and management are key to preventing adverse cardiovascular events.
Abstract

Keywords:
Adults with congenital heart disease (ACHD)Cardiovascular disease (CVD)Coronary heart diseaseOral contraceptivesPregnancy

More Related Videos

Simultaneous Isolation of High Quality Cardiomyocytes, Endothelial Cells, and Fibroblasts from an Adult Rat Heart09:38

Simultaneous Isolation of High Quality Cardiomyocytes, Endothelial Cells, and Fibroblasts from an Adult Rat Heart

Published on: May 19, 2017

13.4K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.3K

Related Concept Videos

Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
496
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.9K
Birth Control Methods01:22

Birth Control Methods

Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
292
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
867
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
540